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Background:MutS, a heterodimer of MSH2 and MSH6, is essential for DNA mismatch repair.
Results: hMsh2G674A-hMSH6wt and hMSH2wt-hMSH6T1219D mutant proteins fail to efficiently license mismatch-provoked,
nick-directed excision.
Conclusion: Different defects underlie the apparently similar repair deficiency of these two mutants.
Significance: Findings provide new insights into themechanismofmismatch repair with implications for cancer predisposition
and the apoptotic response to DNA damaging agents.
The heterodimeric human MSH2-MSH6 protein initiates
DNAmismatch repair (MMR)by recognizingmismatchedbases
that result from replication errors. Msh2G674A or Msh6T1217D
mice that have mutations in or near the ATP binding site of
MSH2 or ATP hydrolysis catalytic site of MSH6 develop cancer
and have a reduced lifespan due to loss of the MMR pathway
(Lin, D. P., Wang, Y., Scherer, S. J., Clark, A. B., Yang, K., Avdi-
evich, E., Jin, B., Werling, U., Parris, T., Kurihara, N., Umar, A.,
Kucherlapati, R., Lipkin, M., Kunkel, T. A., and Edelmann, W.
(2004) Cancer Res. 64, 517–522; Yang, G., Scherer, S. J., Shell,
S. S., Yang, K., Kim, M., Lipkin, M., Kucherlapati, R., Kolodner,
R. D., and Edelmann,W. (2004)Cancer Cell 6, 139–150).Mouse
embryonic fibroblasts from these mice retain an apoptotic
response to DNA damage. Mutant human MutS proteins
MSH2G674A-MSH6wt and MSH2wt-MSH6T1219D are profiled
in a variety of functional assays and as expected fail to support
MMR in vitro, although they retain mismatch recognition
activity. Kinetic analyses of DNA binding and ATPase activ-
ities and examination of the excision step of MMR reveal that
the two mutants differ in their underlying molecular defects.
MSH2wt-MSH6T1219D fails to couple nucleotide binding and
mismatch recognition, whereas MSH2G674A-MSH6wt has a
partial defect in nucleotide binding. Nevertheless, both
mutant proteins remain bound to the mismatch and fail to
promote efficient excision thereby inhibitingMMR in vitro in
a dominant manner. Implications of these findings for MMR
and DNA damage signaling by MMR proteins are discussed.
The evolutionarily conserved DNA mismatch repair
(MMR)2 system has a key role in correcting errors generated
during DNA replication and recombination, and it contributes
substantially to maintenance of genetic fidelity and stability
(3–6). Loss of MMR greatly increases the spontaneous muta-
tion rate, and Lynch syndrome, a cancer susceptibility syn-
drome of the colon and other organs, is caused by inherited
defects in MMR. In addition, the acquired loss of MMR
through epigenetic silencing or somatic mutations is associ-
ated with a large subset of sporadic cancers. MMR proteins are
also required for activation of cell cycle checkpoints and
apoptotic responses to several classes of DNA damaging agents
(4, 7, 8).
MMR can recognize and correct not only basemispairs, such
as G:T, but also insertion/deletion loops that give rise to frame-
shift mutations (9–11). In eukaryotes, the first step of MMR is
the recognition of mismatches by one of two highly conserved
proteins,MutS, a heterodimer ofMSH2 andMSH6 (Fig. 1), or
MutS, a heterodimer of MSH2 and MSH3. MutS targets
both base mispairs and small insertion/deletion loops, whereas
MutS targets small and large insertion/deletion loops (12, 13).
Both MutS and MutS proteins are members of the ABC
transporter family of ATPases, and their ability to bind and
hydrolyze ATP is essential for MMR function (4–6). MutS
contains two compositeATPase sites located at theC termini of
MSH2 and MSH6, with conserved residues from each subunit
contributing to the active site in the other. The two sites are
non-equivalent, with the site inMSH6having higher affinity for
ATP and the site in MSH2 having higher affinity for ADP (14–
16). MutS has been proposed to function as a “molecular
switch” involving communication between the mismatch rec-
ognition and the nucleotide binding sites (17, 18). In this model
mismatch recognition by MutS mediates a rapid exchange of
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ADP for ATP, which in turn leads to conformational changes
that alterMutS interactions with DNA. In vitro, MutS forms
a clamp-like structure that diffuses along the DNA; this effect
requires ATP binding but not ATP hydrolysis (17–19). ATP
binding by MutS is also required for its interaction with
MutL, a heterodimer of MLH1 and PMS2, that mediates ini-
tiation of excision targeted at the error-containing daughter
strand (5, 20).
Consistent with the central role of MutS in detecting and
signaling responses tomismatched and damagedDNA, the loss
of MSH2 or MSH6 activity results in accumulation of somatic
mutations in tumor cells and resistance to the genotoxic effects
ofmanyDNAdamaging agents (4, 21). Edelmann and co-work-
ers generated two knock-in mouse strains harboring
Msh2G674A or Msh6T1217D alleles and found that the mice
developed cancer, exhibited microsatellite instability, and
yielded embryonic fibroblasts that displayed impairedMMR in
vitro. Their reports also indicated these are separation-of-func-
tion alleles in that the MMR response is abrogated, but the
apoptotic response to DNA-damaging agents is retained (1, 2).
The corresponding Saccharomyces cerevisiae mutant alleles
encoding MSH2G693A-MSH6wt and MSH2wt-MSH6G1067D
confer a dominant mutator phenotype (22, 23). Biochemical
studies of MSH2wt-MSH6G1067D suggest that the mutant pro-
tein retains mismatch binding activity but fails to properly
couple mismatch recognition with nucleotide binding and
hydrolysis (16, 24, 25). Relatively little is known about the cor-
responding human MutS proteins hMSH2G674A-hMSH6wt
and hMSH2wt-hMSH6T1219D. Residue Gly-674 is located in the
Walker A ATP binding motif within the conserved C-terminal
ATPase domain of hMSH2, and Thr-1219 is at the hMSH2-
hMSH6 heterodimer interface in close proximity to the ABC
ATPase “signature motif” of hMSH6 and the P loop of the
hMSH2 ATP binding site (Fig. 1) (26). These residues have
functional significance in human MMR, as Lynch syndrome
alleles encode the MSH6T1219I mutation (27), and a mutant
hMSH2 protein having a Gly-674 to Arg substitution is defec-
tive for MMR in vitro (28).
Here we present a detailed characterization of hMSH2G674A-
hMSH6wt and hMSH2wt-hMSH6T1219D mutant proteins using
a battery of in vitro assays to understand the underlying basis
for their MMR defect. We confirm that both mutants fail to
carry out MMR in vitro despite being proficient in mismatch
recognition. Steady-state and pre-steady-state analysis of
hMutS-DNA interactions and ATPase activity reveal that
hMSH2G674A-hMSH6wt and hMSH2wt-hMSH6T1219D pro-
teins, although retaining mismatch recognition and intrinsic
ATP hydrolysis activities, fail to license a robust excision step.
Instead, themutant hMutS proteins remain bound to themis-
match. Our findings provide a more detailed characterization
of the human mutant proteins particularly with regard to exci-
sion, which has not previously been examined, provide amolec-
ular basis for the observed phenotype of the heterozygous
T1217D mouse, highlight differences in the molecular defects
of the G674A and T1219D mutant MutS proteins, and pro-
vide a basis for thinking about how they might mediate the
apoptotic response to certain DNA damaging agents.
EXPERIMENTAL PROCEDURES
Protein Purification—Recombinant hMutS and hMutL
were expressed in insect cells using the baculovirus system and
purified over a 6-mlResourceTMQanion exchange column (GE
Healthcare), 5-ml HiTrapTM Heparin affinity column (GE
Healthcare), and HiLoad 16/60 Superdex 200 sizing column
(GEHealthcare) as described (29). In the final chromatographic
step, wild type hMutS and hMSH2G674A-hMSH6wt were
eluted in buffer A (25 mM HEPES, pH 7.5, 0.1 mM EDTA, 10%
glycerol, 1mMDTT, 1Complete proteinase inhibitormixture
(Roche Applied Science); 0.1% PMSF) containing 100 mM KCl,
whereas MSH2wt-MSH6T1219D was eluted in buffer A contain-
ing 300mMKCl. hMutLwas eluted in buffer A containing 200
mM KCl. Concentrations of MutS and MutL were deter-
mined with a modified Bradford protein assay (Bio-Rad) using
BSA as standard.
For LacI, a fragment containing the ORF of lacI and a C-ter-
minal termination codon was amplified by PCR from pDM1.1
plasmid (30) (gift from Dr. Sankar Adhya, NCI) and inserted
into pBAD/Myc-His vector (Invitrogen) at NcoI and EcoRI
FIGURE 1. Models of human MSH2G674A-MSH6 and MSH2-MSH6T1219D
mutants. Ribbon diagram of the front view and top-down view of the
double ADP-liganded wild type human MSH2-MSH6 structure bound to a
GT mispair (Protein Data Bank code 2O8b) (26). MSH2 is shown in green,
MSH6 is in blue, ADP is in red, and Mg2 is in yellow. Each amino acid
substitution in the respective ATPase domain was modeled into the wild
type structure as shown in the expanded insets. Mutated residues are
demoted by the stick representation. Rotamers were selected for the least
amount of steric hindrance. Expanded images are shown with the sche-
matic ribbons made transparent for better viewing. Molecular images
were generated with the PyMOL Molecular Graphics System, Version 1.3,
Schrödinger, LLC.
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sites. LacI/pBAD was transformed into OneShot TOP10 cells
(Invitrogen). 1 ml of 0.5% w/v arabinose was added to a 1-liter
culture at optical density 0.5. Cells were collected 4 h after
induction, resuspended in lysis buffer (25 mM HEPES, pH 7.5,
100 mM KCl, 0.1 mM EDTA, and 10% glycerol) plus Complete
protease inhibitor (Roche Applied Science), and lysed by soni-
cation. The lysate was passed over a 6-ml Resource Q column
(GE Healthcare), and the flow-through was loaded on a 5-ml
HiTrap-Heparin_HP column (GE Healthcare); LacI eluted
between 300 and 500 mM KCl in lysis buffer. The eluate was
loaded on a 120-ml Superdex 200 column (GE Healthcare)
equilibrated in lysis buffer containing 200 mM KCl. Fractions
containing LacI were stored in lysis buffer plus 200 mM KCl.
Final yield was 8 mg/liter culture.
Mismatch Repair and Excision Assays—Mismatched DNA
substrates were derived from pSCW01 and pSCW02 as
described previously (29). Themismatched DNA substrate was
purified by CsCl/ethidium bromide equilibrium centrifugation
before use. Nicked substrates were prepared by incubationwith
of Nt.BbvCI (5-nick) or Nt.BspQI (3-nick) (New England Bio-
Labs) followed by phenol-chloroform extraction and ethanol
precipitation.
HeLaS3- and hMSH2-deficient LoVo cells (American Type
Culture Collection) were maintained at 37 °C in DMEM (Invit-
rogen) with 10% fetal bovine serum (Invitrogen), 50 units of
penicillin, and 50g/ml streptomycin (Invitrogen) in a 5%CO2,
humidified atmosphere. Nuclear extracts were isolated exactly
as described previously (29). The final nuclear supernatant was
concentrated to 5–8 mg/ml using Amicon Ultracel-10K
(Millipore).
In vitroMMR assays were performed in a 40-l volume con-
taining 75 fmol (100 ng) of nicked heteroduplexDNA, 100g of
nuclear extract, 20–40 nM hMutS proteins, 0.1 mM each of
four dNTPs, 20 mM Tris-HCl, pH 7.6, 1.5 mM ATP, 1 mM glu-
tathione, 5 mM MgCl2, 50 mg/ml BSA, and 110 mM NaCl. The
reactions were assembled on ice, incubated at 37 °C for 15 min,
and terminated by proteinase K addition (New England Bio-
labs). The restored DNAwas digested either with PstI and AseI
endonuclease (nickedpSCW01_GT) orwith FauI andAseI sub-
sequently (nicked pSCW02_GT) as described previously
(29). The repair yield equals the ratio of the summed intensities
of the 0.8- and 1.2-kb fragments to the total intensity of the 0.8-,
the 1.2-kb, and the 2.0-kb bands.
Excision assays were performed as described above forMMR
assays except that exogenous dNTPs were omitted, and the
reaction was incubated for 7 min. The DNAwas recovered and
digested with AseI and annealed with a 32P-labeled oligomer
probe to visualize the excision intermediates, which were
resolved by gel electrophoresis (29, 31). Two probes were uti-
lized: 5-GAG GGT TAT TGT CTC ATG AGC GGA TAC
ATA-3 (probe 1) and 5-CTCATTCCCGCAGCGACTCCA
TGG GAC TCA-3 (probe 2). Ethidium bromide staining was
used to normalize DNA recovery and loading. The gel was
dried, and the radioactivity was measured by Fuji phosphorim-
aging BSA-2500.Mismatch-provoked excision assays were also
visualized using Southern blotting analysis essentially as
described (29, 32). 5-Excision products were digested with
AflII or PciI (New England Biolabs), whereas 3 excision prod-
ucts were cleaved with PvuI or XhoI (New England Biolabs).
After separation on 6% denaturing polyacrylamide gels, the
DNA excision intermediates were transferred to Hybond-NX
membranes (Amersham Biosciences), cross-linked, and then
probed with a 32P-5 end-labeled oligonucleotide. Four probes
were utilized: 5-TTGGAGCGAACGACC TACACCGA-3
(AflII digestion); 5-CCT GCG TTA TCC CCT GAT TCT
GT-3 (PciI digestion); 5-CCA TGA GTG ATA ACA CTG
C-3 (PvuI digestion); 5-TGC TTC AAT AAG CTG TGC-3
(XhoI digestion). Membranes containing reaction products
were analyzed using Fuji phosphorimaging BAS-2500 and
ImageGauge V4.22.
DNA Binding; Electrophoretic Mobility Shift Assays (EMSA)
and Fluorescence Anisotropy—EMSA assays were as described
previously with minor modifications utilizing gel-purified,
5-32P-radiolabeleed 35-bp duplex substrates containing a G:T
mispair or corresponding homoduplex A:T control (33). The
sequences were 5-CGGATCCGACTCATTCCTGCAGCG
ACT CCA TGG GA-3 (plus strand) and 5-TCC CAT GGA
GTC GCT GCA/G GGA ATG AGT CGG ATC CG-3 (minus
strand), where bold denotes G:T mispair position. DNA bind-
ing reactions (10 l) contained 25 mM Tris-HCl, pH 7.4, 6 mM
DTT, 10% glycerol, 50 g/ml bovine serum albumin, 2 mM
MgCl2, 100mMNaCl, 0.25 nM 32P-labeled oligonucleotides, 5.2
ng/l EcoRI-digested Lambda DNA (Fermentas) and the indi-
cated protein. Themixtures were incubated at 24 °C for 15min,
mixed with 10l of 50% (v/v) glycerol, 0.5Tris borate-EDTA
and 0.2% of DNA gel loading solution (Quality Biological), and
then loaded onto a 6% native polyacrylamide gel (Invitrogen)
that was pre-electrophoresed for 10 min. Samples were sub-
jected to electrophoresis at room temperature at 220 V in 1
Tris borate-EDTA buffer and visualized by Fuji phosphorimag-
ing BAS-2500 after drying.
DNA substrates for fluorescence anisotropy assays were pur-
chased from Integrated DNA Technologies, Inc. (Coralville,
IA), and their sequences were 5-TAC CTC ATC TCG AGC
GTG CCG ATA-TAMRA-3 and the complement 5-TAT
CGG CAC GTT CGA GAT GAG GTA-3 (the mismatched
base is underlined). The strands were annealed in 20 mM Tris-
HCl, pH7.8, 100mM sodiumacetate, 5mMmagnesiumchloride
in 1:1 molar ratio by heating at 70 °C for 20 min and slow
cooling to room temperature. DNA binding was measured by
titrating the proteins into a solution of 5 or 10 nM DNA in the
annealing buffer in the absence or presence of 1 mM ADP or
ATP. TAMRA anisotropy was measured at EX 553 nm and
EM 574 nm in a Horiba Jobin Yvon Fluorolog-3 at 23 °C. Bind-
ing data were fit as described previously (34).
Surface Plasmon Resonance Analysis—Surface plasmon res-
onance (SPR) measurements were performed on a BIAcore
3000 (GE Healthcare). Control homoduplex (A:T) and mis-
matched (G:T) 238-bp DNA substrates were prepared from
PCR fragments using a modification of a previously described
method (18). The T base of G:T was 106 nt from the 5 end of
the biotinylated strand. The A:T substrate was made by PCR
amplification of pSCW02 plasmid with a PstI site at position
186 (182CTGCAG; bold denotes the position ofA:T; numbering
refers to pSCW02 (29)) using a biotinylated forward primer
(5-GGA TAC ATA TTT GAA TGT ATT TAG AAA AAT
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AAA CAA ATA GGG G) and a nonphosphorylated reverse
primer (5-TCA CACATC aat tgt tat ccg ctc aca att CCG CTC
GCC GCA GCC GAA CGA CCG) in which lowercase denotes
a lacO operator sequence. A:T substrates were confirmed to be
PstI and FauI.
The G:T substrate was made from two different PCR frag-
ments. The T strand is from the A:T PCR fragment (PstI and
FauI) described above except the reverse primer containing a
lacOoperator sequencewas 5-phosphorylated. TheG strand is
derived from a PCR fragment of a second plasmid template,
pSCW02_CG, produced by replacing T with C in pSCW02,
resulting in loss of the PstI site and gain of a new FauI site
(CCCGCN4). The primers were as used for the A:T substrate,
except the forward primer was 5-phosphorylated and had no
biotin. The reverse primer containing a lacO operator sequence
was unphosphorylated. These two intermediate PCR fragments
were incubated with  exonuclease (New England Biolabs) to
remove the 5-phosphorylated strand of double-stranded PCR
fragment. The biotinylated T strand and the G strand were
annealed to each other by heating at 95 °C and slow cooling (2
h) to create a new double-stranded G:T substrate that was
resistant to cleavagewith either PstI or FauI. The 238-bpA:T or
G:T DNA was immobilized on a streptavidin-coated SA Bia-
core chip (GE Healthcare).
Interactions of hMutS and hMutS-hMutL ternary com-
plex with DNA were measured as described with minor modi-
fication (33, 35). Briefly, 25 nM hMutS was flowed over the
DNA in running buffer containing 20 mM Tris-HCl, pH 7.6, 1
mMDTT, 0.005% surfactant P20, 5mMMgCl2, 110mMKCl at a
flow rate of 20 l/min. After equilibrium was reached, dissoci-
ation kinetics were measured by co-injecting either running
buffer alone or running buffer with 1 mM ATP or ADP. SA
sensor ChiPs were regenerated by a 20-l injection of 0.5%
SDS.
hMutS dissociation from the end-blocked DNA substrates
was measured by including 50 nM LacI in the running buffer
during the equilibration and hMutS binding phases. After
hMutS association, running buffer with either 1mMATP plus
50 nM LacI or 1 mM ATP plus 1 mM IPTG was flowed over the
SA sensor chip to monitor dissociation.
Binding of hMutL andhMutS on theDNAsubstrate could
be measured only in the presence of ATP. Briefly, 25 nM
hMutSwas flowed overDNA in the running buffer containing
1 mM ATP for 10 min or first for 5 min then coinjected with 25
nMhMutL for another 5min.All experimentswere performed
at 25 °C, and samples were maintained at 4 °C before injection.
Steady-state ATPase Assay—hMutS steady-state ATPase
activity was measured at 30 °C by the malachite green assay as
described (36) with some modifications. The reaction con-
tained 0.5 M wild type or mutant hMutS, 0.5 mM ATP in the
absence or presence of 1 M 35-bp A:T or G:T DNA in 30 mM
Tris-Cl, pH 7.5, 5mMMgCl2, 110mMKCl, 0.1mg/ml BSA. The
DNA sequences were the same as described above in EMSA
assays. Reactions were initiated with hMutS, 30-l aliquots
were quenched with equal volumes of ice-cold 0.6 M perchloric
acid at various times, and the inorganic phosphatewas analyzed
by the malachite green assay.
hMutS-DNA Association/Dissociation Kinetics—hMutS
binding toDNAwasmonitored by changes in fluorescence ani-
sotropy of the 35-bp DNA labeled with 5-(and 6-) carboxyte-
tramethylrhodamine (TAMRA; Invitrogen) at the 3 end
(G:TTAMRA). 0.8 M wild type or mutant proteins were mixed
rapidly in 1:1 ratio with 0.16 M G:TTAMRA in steady-state
ATPase buffer on a stopped-flow instrument (KinTek Corp.,
Austin, TX), and fluorescence anisotropy was monitored over
time (polarized EX  550 nm and EM  570 nm) at 30 °C.
hMutS dissociation fromDNAwasmeasured under the same
conditions by mixing preformed hMutS-G:TTAMRA complex
(0.8MhMutS, 0.16MDNA) 0.2mMADP in 1:1 ratiowith
an excess of unlabeled 35-bp G:T DNA (12 M)  an excess
ADP or ATP (1–4 mM). Three or more kinetic traces were
averaged for each experiment and fit empirically to single or
double exponential functions to estimate the rate constants.
hMutS-2-(or-3)-O-(N-methylanthraniloyl)adenosine 5-
diphosphate (MantADP) Association/Dissociation Kinetics—
hMutS binding to mantADP (Invitrogen) was measured by
stopped-flow experiments at 30 °C. 0.4 M hMutS  1.2 M
G:T DNA was mixed rapidly in 1:1 ratio with 20 M mantADP
in 25mMHepes-NaOH, pH 7.5, 10mMMgCl2, 100mMKCl, 0.1
mg/ml BSA, and fluorescence was monitored over time (EX 
352 nm and EM  420 nm). MantADP dissociation from
hMutS was measured under the same conditions by mixing
preformed hMutS-mantADP complex (0.4 M hMutS, 20
MmantADP) 1.2 MG:TDNA in 1:1 ratio with excess ATP
(8 mM). Three or more kinetic traces were averaged for each
experiment and fit empirically to single or double exponential
functions to estimate the rate constants.
RESULTS
hMutS Mutants Fail to Carry Out MMR in Vitro—Recom-
binant wt hMSH2-hMSH6, hMSH2G674A-hMSH6wt (denoted
as G674A), and hMSH2wt-hMSH6T1219D (denoted as T1219D)
proteins (supplemental Fig. S1) were assessed for their ability to
support MMR in an in vitro assay using nuclear extracts from
LoVo cellsmissing hMutS. Correction of aG:Tmispair toG:C
in a 5-nicked pSCW01_GT mismatched substrate restores a
cryptic PstI cleavage site. Thus, after MMR, the corrected sub-
strate yielded 0.8- and 1.2-kb fragments when cleaved with PstI
and AseI. The uncorrected G:T substrate linearized by AseI
yielded a 2.0-kb fragment. As indicated in Fig. 2A, there was
little if anyMMR activity in LoVo cell nuclear extracts, whereas
HeLa cell nuclear extracts yielded close to an 80% correction of
the G:Tmispair. As noted previously, repair does not approach
100% due in part to ligation of the nicked substrate by ligases in
the nuclear extracts, rendering the covalently closed plasmid
resistant to MMR (37). The addition of recombinant hMutS
WT protein restored MMR activity in LoVo extracts, with
50% of the substrate being repaired. The G674A hMutS
mutant had lowMMR activity, with 10% of the substrate being
repaired, and the T1219D mutant had no detectable repair
activity. With respect to the low level of MMR observed above
in the case of the G674A mutant (Fig. 2A, lanes 7 and 8), it is
possible that randomnuclease activity present in LoVo extracts
(see below; Fig. 3, B and C, lane 2) could contribute to this
apparent MMR. Nevertheless, for reasons outlined below, we
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believe that the G674A mutant retains very low levels of bona
fideMMR activity.
hMSH2G674A-hMSH6wt (G674A) and hMSH2wt-
hMSH6T1219D (T1219D) were also deficient in 3-nick-di-
rected repair of the pSCW01_GT DNA substrate, as shown in
Fig. 2B. In control experiments, HeLa cell nuclear extracts
yielded 20% repair, and LoVo extracts supplemented with
recombinant wild type hMutS corrected 16% of the substrate.
Although 3-directed mismatch repair, which depends on the
endonuclease activity of MutL, was not as robust in vitro as
5-directed MMR, as noted previously (38, 39), it was apparent
that the G674A mutant exhibited very limited MMR activity
(4%), and the T1219Dmutant failed to promote any detectable
3-directed MMR.
MMR activity was assayed with a second DNA substrate,
pSCW02_GT, containing a G:T mispair. Correction of the G:T
mispair to G:C introduces a FauI cleavage site. Thus,MMRwas
monitored by the generation of 0.8- and 1.2-kb fragments after
digestion with FauI and AseI (29). Both G674A and T1219D
mutants failed to carry out either 5- or 3-nick-directed MMR
with the pSCW02_GTDNA substrate (data not shown). Our in
vitro observations are consistent with the previous knock-in
mouse models demonstrating that MutS G674A and T1219D
mutants are defective for MMR activity in vivo (1, 2).
The question of whether the G674A and T1219D mutants
can suppress endogenous MMR activity, i.e. whether they
exhibit dominant negative behavior, was addressed by carrying
outMMRwithHeLa nuclear extracts in the presence of recom-
FIGURE 2. MutS mutants are unable to perform MMR. A, MutS G674A (GA) and T1219D (TD) mutants are defective for 5-nick-directed MMR. Upper
panel schematic, 5-nick-directed MMR restores a cryptic PstI cleavage site in the pSCW01_GT mismatched substrate. PstI together with AseI were
chosen to make the diagnosis of MMR. Lower panel, MMR assays were performed with HeLa or LoVo nuclear extracts and MutS proteins as indicated.
Lane 1, control, covalently closed pSCW01 homoduplex and 5-nicked pSCW01_GT in the absence of nuclear extract used for quantitation. Lane 2,
control, covalently closed pSCW01 homoduplex in the absence of nuclear extract. Lane 3, control, 5-nicked pSCW01_GT in the absence of nuclear
extract. B, MutS G674A and T1219D mutants are defective for 3-nick-directed MMR. Upper panel, 3-nick-directed MMR restores PstI cleavage. Lower
panel, MMR assays were carried out as in A except that the pSCW01_GT DNA substrate was nicked with Nt.BspQI (3-heteroduplex). C, MutS mutants
inhibit MMR in HeLa cell extracts. Experiments were performed as in A, except that MutS proteins were incubated with HeLa nuclear extracts. The
asterisk denotes PstI and AseI cleavage products.
Human MutS Mismatch Repair Mutants
MARCH 23, 2012 • VOLUME 287 • NUMBER 13 JOURNAL OF BIOLOGICAL CHEMISTRY 9781
Human MutS Mismatch Repair Mutants
9782 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 13 • MARCH 23, 2012
binantWT, G674A, or T1219D hMutS proteins. As shown in
Fig. 2C, excess exogenous hMutS inhibited normal MMR in a
dose dependent manner. 30 nM wild type hMutS lowered
MMR efficiency to 34% repair compared with 51% by HeLa
extract alone. A more substantial inhibition of MMR was
observed in the presence of 30 nM G674Amutant (15% repair),
whereas the T1219Dmutant inhibited all but a residual level of
MMR (7% repair). These data provide strong evidence that both
G674A and T1219D mutants behave in a dominant negative
fashion with respect to MMR in vitro.
hMutSMutants Can Recognize G:TMispair—The ability of
MutSG674A andT1219Dmutant proteins to recognize aG:T
DNA mismatch, the initial step in MMR, was examined by
EMSA and fluorescence anisotropy. Qualitative assessment of
mismatch recognition by EMSA revealed that the G674A and
T1219D mutants retained mismatch binding activity and the
ability to discriminate between G:T mispairs and homoduplex
DNA (supplemental Fig. S2, A and B). Quantitative assessment
by fluorescence anisotropy revealed high affinity binding toG:T
by all the proteins in the absence of nucleotides or in the pres-
ence of ADP (Table 1). As expected, wild type hMutS affinity
for G:T was substantially reduced in the presence of ATP, in
agreement with a previous report (40). In contrast, mismatch
binding by the G674A and T1219D mutants was insensitive to
ATP (Table 1).
hMutS Mutants Block Excision—Mismatch recognition by
MutS is followed by an excision step directed to the newly
synthesized strand containing the error. The ability of hMutS
G674A and T1219D mutants to signal excision was assayed by
MMRassays inwhich dNTPswere omitted. After incubation of
the G:TMMR substrate containing a 5-nick with LoVo extract
and either wild type, G674A, or T1219D proteins, the DNAwas
linearized by AseI and annealed to 32P-labeled oligonucleotide
probes complementary to sequences at varying distances from
the initiating nick. Probe 1 is adjacent to the 5-nicking site, and
probe 2 spans the mismatch site. As shown in Fig. 3A, random
nuclease activity initiating at the nick was observed in LoVo
extract alone and supplemented with wild type or mutant
hMutS proteins. Similar activity was seen at the nick in anA:T
homoduplex substrate andwas largely independent of hMutS.
Probe 2 revealed that the addition of wild type hMutS resulted
in significant excision in the vicinity of the G:T mismatch over
the background level. In contrast, the G674Amutant quenched
background level excision near the mismatch, and this effect
wasmore pronounced in the case of the T1219Dmutant. These
data reveal that G674A only weakly supports extensive excision
of the mispaired base, whereas T1219D is completely deficient
for this step. Both mutants can block excision whether it be
EXO1-mediated or spurious in nature.
To map more precisely the extent of excision that results in
gapped DNA intermediate(s), we performed Southern blot
experiments using two probes complementary to the nicked
strand. Excision assays were performed with nicked G:T or A:T
homoduplex substrate that was incubated with LoVo extract
and recombinant wild type, G674A, or T1219D hMutS and
then linearized by AflII. For 5-nick-directed excision, the
probe was located 664 nt from the Nb.BbvCI nick site. Excision
is predicted to generate a family of shorter fragments; e.g. exci-
sion to the mismatch site would generate a 127-nt gap and a
537-nt radiolabeled product. As shown in Fig. 3B, all samples
yielded a low background level of random excision with the
nicked homoduplex (A:T). LoVo extract alone (Fig. 3B, lanes 2
and 8) yielded similar patterns of excision fragments for both
G:T andA:TDNAsubstrates, reflecting randomexcision that is
not mismatch-directed. With the addition of wild type
hMutS, excision was restored to the level observed with HeLa
nuclear extract, and the gap was extended up to several hun-
dred nucleotides beyond the mismatch, consistent with prior
observations (5, 32). The G674A mutant promoted limited
excision beyond the mismatch, yielding a pattern of excision
that resembles that of wild type MutS, and is distinct from
LoVo extract alone. The prominent presence of a fragment
larger than 537 nt indicates that, for the most part, excision
terminated prematurely before reaching themismatch site. The
T1219D mutant was also unable to promote excision to the
mismatch, and a strong termination position was detected
upstream of the mismatch site. These data indicate that 5-di-
rected excision can initiate with low frequency in the case of the
G674A mutant (compared lanes 2 and 4 in Fig. 3B) but is not
supported by the T1219D mutant. Moreover, spurious exonu-
FIGURE 3. MutS mutants block excision. A, MutS G674A (GA) and T1219D (TD) are defective for 5-nick-directed mismatch-provoked excision
assayed by hybridization of probes to the un-excised strand. Upper panel, the schematic depicts the 5-nick-directed excision assay measured by
annealing probe 1 or 2 identical to the excised strand. Lower panel, excision assays were performed as described for MMR assays but with the omission
of exogenous dNTPs using pSCW02_GT or pSCW02 homoduplex (A:T) DNA substrates. B, MutS G674A and T1219D were defective for 5-nick-directed
excision assayed by Southern blotting after cleavage with AflII. Upper panel, 5 nick-directed excision assay by Southern blotting. The distance from the
AflII cleavage site to the Nb.BbvCI nick site on the top strand is 664 nt. The position of the G:T mismatch is denoted by the triangle and is located 537 nt
from the AflII site (denoted by an asterisk in the lower panel). Lower panel, excision assays were monitored by Southern blotting. Nicked A:T homoduplex
was used to measure random excision. C, MutS G674A and T1219D are defective for 5-nick-directed excision assayed by Southern blotting after
cleavage with PciI. 5-Nick-directed excision assays were performed as in B, but the gapped 5-nicked DNA substrates were digested with PciI. D, MutS
G674A and T1219D were defective for 3-nick-directed excision assayed by Southern blotting after cleavage with PvuI. Upper panel, the schematic
depicts multiple cleavage sites generated by MutL. The distance from the PvuI cleavage site to the 3-nick generated by Nt.BspQI is 600 nt. The distance
from the PvuI site to the mismatch is 550 nt (denoted by an asterisk). E, MutS G674A and T1219D are defective for 3-nick-directed excision, assayed by
Southern blotting after cleavage with XhoI. The bracket indicates incision intermediates, and the triangle represents a larger 3 incision (see “Results”).
TABLE 1
Nucleotide dependence of hMutS WT, G674A, and T1219D mutants
on binding to a 24-base pair G:T heteroduplex DNA
Dissociation constants (Kd) were determined for hMutS and mutants with 24-bp
G:T heteroduplex DNA substrates by fluorescence anisotropy (see “Experimental
Procedures”) in 100 mM NaOAc in the absence or presence of 1 mM ATP or ADP.




hMutS WT 7.5  7 107.9  26 8.9  8.8
hMutS G674A 15.4  14 6.6  4 6.2  8
hMutS T1219D 5.2  1 6.3  3 10.8  3
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cleolytic degradation is largely blocked by these two mutants
that remain tightly bound to the mismatch.
Finemapping of excision tracts was carried out using the PciI
cleavage site, which is 296 nt away from the 5-nick site, and
yields a 169-nt radiolabeled product if excision reaches themis-
matched base. In the case of LoVo extract supplemented with
wild type hMutS or for the HeLa nuclear extract control, a
family of DNA fragments that reflected excision tracts extend-
ing 50 nt or more beyond the mismatch was generated. The
addition of G674A or T1219D to the LoVo reaction resulted in
strong excision stops just 5 to the mismatch site (Fig. 3C).
Therefore, in the presence of these two mutant proteins, exci-
sion initiated at the nick butwas terminated before reaching the
mismatch. These results suggested that theG674AandT1219D
hMutS mutants remained bound to their target site and
blocked excision.
We also explored the ability of wild type MutS and the
G674A and T1219D mutants to support 5-nick-directed exci-
sion of anO6-methylguanine (O6-meG):Tmispaired DNA sub-
strate, a cytotoxic mismatch resulting from DNA alkylation by
the Sn1 class of DNA alkylating agents. As indicated in the
right-hand panels of Fig. 3B-C, a low level of background exci-
sion was observed in the presence of LoVo extract alone. The
addition of wild type hMutS restored excision to levels similar
to that of HeLa nuclear extract. The G674A mutant supported
limited excision beyond the mismatch, whereas the T1219D
mutant failed to promote excision to themismatch, resulting in
a strong termination position upstream of the mismatch site.
These data revealed that the MutS G674A and T1219D
mutants behaved similarly in vitro with respect to 5-directed
excision in the case of O6-meG:T and G:T mismatches.
The G674A and T1219D mutants were also evaluated for
their ability to promote 3-nick-directed excision in an analo-
gous assay in which excision is directed from aNt.BspQI site 50
nt 3 to the mismatch on the top strand of the G:T pSCW02
substrate. 3-Nick-directed excision requires the endonucleo-
lytic activity of MutL, which incises the newly synthesized
strand on both sides of the mismatch providing a substrate for
5- 3 3-mediated excision by EXO1 (38, 39). The distance
from the PvuI cleavage site to the Nt.BspQI nick is 600 nt (Fig.
3D). For theG:Tmispair, very low levels of nonspecific excision
were observed in reactions containing LoVo extract alone. In
the presence of recombinant WT hMutS, excision was
restored to a similar level as in theHeLa nuclear extract control,
and gaps extended to 450 nt in length reflecting endonucleo-
lytic cleavage by MutL up to several hundred nucleotides
upstream of the mismatch followed by EXO1 processing. The
G674A mutant promoted much weaker excision, whereas the
T1219D mutant failed to support any significant excision.
Digestion of 3-nick-directed excision products with XhoI
located 216 nt away from the nick site and 166 nt from the
mispair confirmed that the G674A mutant supported limited
3-nick-directed excision, whereas the T1219Dmutant did not
support any detectable excision (Fig. 3E). Experiments with
3-nicked homoduplex A:T DNA show very low background
levels of nonspecific 3 to 5 excision in LoVo and HeLa
extracts. Close examination of the excision tracts revealed that
the G674A mutant, but not the T1219D mutant, supported
initial endonucleolytic incisions by MutL on both sides of the
mismatched top strand that give rise to incised DNAs that
could be further processed by EXO1. These excision interme-
diates constitute a family of DNA fragments denoted by the
bracket in Fig. 3E. The percentage of these MutL cleavage
intermediates as a function of total DNA substrate was quanti-
fied. HeLa cell extracts yielded conversion of 29% that of start-
ing substrate to excision intermediates for the G:T mismatch;
the addition of recombinant hMutS WT protein to LoVo
extracts resulted in cleavage of 21% of the substrate. G674A
supported nucleolytic processing of 11% of the mismatched
DNA. Comparison of G674AwithWT reveals the presence of a
larger intermediate in the case of G674A, denoted by a triangle.
This position maps to an incision on the 3 side of the mis-
match, presumably a result of MutL endonuclease activity.
We postulate that G674A can support limited MutL endonu-
cleolytic cleavage but is not as effective as wild type MutS at
promoting subsequent EXO1 processing from these sites.
3-Nick-directed excision of an O6meG:T DNA substrate mir-
rored the G:T mismatched DNA substrate under the same
experimental condition (data not shown).
The excision assays suggest that there is a significant differ-
ence regarding the molecular defects of G674A and T1219D
mutants. T1219D fails to support either 5- or 3-nick-directed
excision, the latter consistent with its inability to productively
interact withMutL (see below). G674A can triggermismatch-
dependent endonucleolytic excision by MutL, although to a
lesser extent than wild type MutS, but subsequent EXO1
processing appears to be substantially diminished.
ATP Modulation of Mismatch Binding—Because ATP bind-
ing and hydrolysis by MutS is critical for MMR, the mutant
proteins were tested for their ATP hydrolysis activity and the
effects of nucleotide binding on their interaction with DNA.
Gly-674 resides in the P loop of the ATPase active site of
hMSH2 that is critical for ATP binding. Thr-1219 resides at the
hMSH2-hMSH6 heterodimer interface, adjacent to the ABC
transporter ATPase signature motif that is critical for ATP
hydrolysis.
As shown by the kcat values in Table 2, wild type hMutS
hydrolyzes ATP at a slow steady-state rate in the absence of
DNA, which is stimulated20-fold in the presence of G:Tmis-
matchedDNA. Surprisingly, bothG674A andT1219Dmutants
exhibit 10-fold faster kcat than wild type protein in the
absence of DNA. Moreover, in contrast to wild type hMutS,
the steady-state ATPase rates of the mutants are severely sup-
pressed in the presence of G:T mismatched DNA (and
TABLE 2
The effect of DNA binding on steady-state ATPase activity of hMutS
WT, G674A, and T1219D mutants
Steady-state kinetics of ATP hydrolysis activity (kcat) of hMutS and mutants were
measured by malachite green assay with 0.5 mM ATP in the absence or presence of
35-bp A:T homoduplex or G:T mismatched DNA substrate in 110 mM KCl (see
“Experimental Procedures”). Values represent the means  S.D. (n  3).
No DNA A:T G:T
s1 s1 s1
hMutS WT 0.03  0.001 0.47  0.005 0.68  0.010
hMutS G674A 0.26  0.003 0.42  0.005 0.03  0.002
hMutS T1219D 0.39  0.015 0.89  0.033 0.02  0.001
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O6meG:T DNA; data not shown), indicating misregulated
activity (no such suppression is observed in the presence of a
homoduplex DNA) (Table 2). These results show that the
mutant proteins retain the ability to bind mismatched DNA
and hydrolyze ATP, but the ATPase mechanism and commu-
nication between themismatch binding and nucleotide binding
sites is disrupted, leading to aberrant activity.
The effects of nucleotides on DNA binding and dissociation
kinetics were investigated by stopped-flow experiments moni-
toring fluorescence anisotropy of a 35-bp DNA containing a
central G:Tmismatch and labeled with TAMRA dye at a 3 end
(G:TTAMRA). Wild type hMutS and the G674A and T1219D
mutants bind DNA rapidly (Fig. 4A) and dissociate at a slow
rate from DNA in the absence of nucleotide (koff  0.002 s1;
Fig. 4B). ATP stimulated rapid dissociation of wild type
hMutS (1000-fold increase in koff) but had a much smaller
effect onG674A (5-fold increase in koff) andno significant effect
on the T1219Dmutant (Fig. 4C).Wild type hMutS dissociates
more rapidly from aG:Tmismatch in the presence of ADP than
in the absence of nucleotides (Fig. 4D), consistent with previous
reports (18, 19, 41, 42). The two mutants also exhibit slightly
faster dissociation in the presence of ADP. Adding ATP to a
ternary complex of ADP-hMutS-G:TTAMRA further stimu-
lated dissociation of wild type hMutS from DNA (7.5-fold
increase over koff with ADP alone) but had a smaller effect on
G674A and no effect on T1219D (Fig. 4E). These results dem-
onstrate that the G674A and T1219D mutants do not couple
mismatch recognition and nucleotide binding like wild type
hMutS.
The above finding led us to test whether the mutants
can undergo the mismatch binding-induced ADP-to-ATP
exchange and sliding clamp formation associated with an acti-
vated state of MutS that can license the excision step. Stopped-
flow experiments measuring mantADP binding and dissocia-
tion kinetics showed that wild type hMutS bound to G:T
mismatch undergoes rapidmantADPbinding and releasewhen
challenged with ATP (koff  1 s1) (Fig. 5,A and B). G:T-bound
G674A exhibited similarmantADPbinding and release kinetics
as wild type protein, although the fraction of bound mantADP
was lower in the absence of DNA (Fig. 5,C andD). T1219D also
exhibited lower mantADP binding and release compared with
wild type protein (Fig. 5, E and F). Thus, the G674Amutant and
especially the T1219D mutant do not bind and exchange ADP
for ATP upon mismatch binding as effectively as wild type
hMutS. This nucleotide exchange is critical for the formation
of a MutS sliding clamp, and the lack of this exchange is con-
sistent with a significant fraction of the mutants remaining
tightly bound to the mismatch site.
hMutS Mutants Are Defective for Sliding Clamp Forma-
tion—The ability of WT, G674A, or T1219D hMutS to form
sliding clamps onmismatchedDNAwas tested directly by SPR.
These studies utilized a 238-bp G:T mismatch heteroduplex or
the corresponding A:T homoduplex having one biotinylated
end for immobilization on the streptavidin-coated sensor chip;
the distal DNA end contained a lacO binding site that could be
blocked by introduction of LacI repressor protein and subse-
quently unblocked by introduction of IPTG (18). hMutS WT,
G674A, andT1219Dproteins boundunblockedDNArapidly in
the absence of nucleotides, and the extent of binding to G:T
mismatch DNA was significantly greater than to A:T homodu-
plex DNA (Fig. 6A, compare solid and dotted lines). Dissocia-
tion from DNA in the absence of nucleotide was slow in all
cases.
In the presence of ATP, WT hMutS dissociated rapidly
from the unblocked DNA (Fig. 6B), as expected for a sliding
clamp of hMutS that diffuses along the duplex. Consistent
with the fluorescence anisotropy results (Table 1), ATP only
modestly accelerated dissociation of the G674A mutant from
DNA and had little discernible effect on T1219Dmutant disso-
ciation. ADP accelerated the dissociation of wild type hMutS
compared with the absence of nucleotides, but dissociation by
G674A and T1219D appeared to be largely resistant to modu-
lation by ADP (Fig. 6C). ADP is known to reduce DNA binding
and increase the specificity of mismatch recognition by MutS
and MutS (18, 19, 41, 42). Inclusion of ADP during the SPR
association phase resulted in reduced wild type hMutS bind-
ing to both G:T and A:T DNA (data not shown). Subsequent
addition of ATP greatly enhanced WT hMutS dissociation
fromDNA.G674AandT1219D failed to exhibit any discernible
effects of ADP on DNA binding or dissociation, and ATP only
modestly stimulated dissociation of the G674A mutant from
the G:T DNA.
Our findings predicted substantial defects in the ability of the
G674A and T1219D mutants to form an ATP-dependent slid-
ing clamp. This finding was confirmed in SPR experiments per-
formed in the presence of LacI protein that blocks the distal
DNAend.As shown in Fig. 6,D andE,WT,G674AandT1219D
hMutS proteins remained bound to theG:TDNA substrate in
the presence of LacI. When LacI binding was reversed by the
addition of 1 mM IPTG, wild type hMutS protein rapidly dis-
sociated from DNA in the presence of ATP, consistent with
formation of a sliding clamp. G674A exhibited gradual dissoci-
ation, suggesting that this mutant protein can assume a sliding
clamp conformation in the presence of ATP but with greatly
reduced efficiency compared with wild type. The T1219D
mutant showed little dissociation under the same conditions.
Together these data reveal that hMutS G674A and T1219D
mutants are differentially compromised for effective nucleotide
exchange and sliding clamp formation after binding to mis-
matched DNA.
hMutS Mutants Are Defective in Ternary Complex Forma-
tion with hMutL—Because G674A and T1219D exhibited
defective coupling of nucleotide andmismatchedDNAbinding
activities, which is required for the productive interaction of
MutS and MutL, we asked whether these mutant proteins
could form a ternary complexwith hMutL. As shown in Fig. 7,
A–C, wild typeMutS bound to aG:Tmismatch readily formed
a ternary complex with MutL in the presence of ATP. In con-
trast, G674A was much less proficient, and T1219D was com-
pletely deficient in ternary complex formation with MutL.
MutL by itself exhibited no detectable binding tomismatched
DNA under these conditions (data not shown).
DISCUSSION
Biochemical studies of two mutant hMutS proteins,
hMSH2G674A-hMSH6wt and hMSH2wt-hMSH6T1219D, corre-
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FIGURE 4. MutS mutants are defective in ATP binding-induced dissociation from G:T mismatched DNA. DNA binding and dissociation by wild type
(red), G674A (blue), and T1219D (green) proteins were monitored by fluorescence anisotropy of G:TTAMRA in stopped-flow experiments. Single or double
exponential fits of the data are solid lines through averaged traces in the same colors. A, DNA binding was measured by mixing MutS with DNA in the absence of
nucleotide. Final reactions contained 0.4 M MutS, 0.08 M G:TTAMRA. B and C, DNA dissociation was measured by mixing MutS-G:TTAMRA complex with excess
unlabeled G:T trap DNA in the absence (B) or presence (C) of ATP. Final reactions contained 0.4 M MutS 0.08 M G:TTAMRA, 6 M unlabeled G:T  0.5 mM ATP. D and
E, the effect of ADP was assessed by incubating ADP with MutS-G:TTAMRA complex and then mixing with excess unlabeled G:T DNA and ADP (D) or ATP (E). Final
reactions contained 0.4 M MutS  0.1 mM ADP  0.08 M G:TTAMRA, 6 M unlabeled G:T  2 mM ADP or ATP.
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sponding to murine alleles that confer MMR deficiency, can-
cer, and shortened lifespan in mice, reveal that these human
mutant proteins recognize mismatches but fail to support
the excision step of MMR. Although both mutants are capa-
ble of hydrolyzing ATP, normal communication between the
mismatch and nucleotide binding domains is disrupted. The
FIGURE 5. MutS T1219D mutant exhibits defects in nucleotide binding and exchange. ADP binding and release by wild type (red), G674A (GA, blue), and T1219D
(TD, green) MutS proteins were monitored by mantADP fluorescence in stopped-flow experiments. A, C, and E, the effect of G:T binding on MutS-
mantADP interaction was examined by mixing either MutS alone (light-colored traces) or G:T-bound MutS (dark-colored traces) with mantADP. Final reactions contained
0.2 M MutS  0.6 M G:T, 10 M mantADP. B, D, and F, mantADP release was monitored by mixing MutS-mantADP (light-colored traces) or MutS-mantADP-G:T
(dark-colored traces) complex with excess cold ATP. Final reactions contained 0.2 M MutS  10 M mantADP  0.6 M G:T, 4 mM ATP.
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mutant proteins behave as dominant inhibitors of MMR in
vitro, most likely because they fail to efficiently form an
ATP-induced sliding clamp upon mismatch recognition,
remain trapped at the mismatch site, and fail to license exci-
sion of the mismatch.
Despite similar MMR deficiencies for these two mutant
hMutS proteins and similar phenotypes of mutant mice
harboring corresponding single amino acid substitutions
in murine MSH2 and MSH6, careful examination of
hMSH2G674A-hMSH6wt and hMSH2wt-hMSH6T1219D pro-
teins reveals that they differ from each other in the molecular
basis of their MMR defect. Whereas T1219D is essentially
unable to support mismatch repair steps subsequent to mis-
match recognition, G674A exhibits a low level of functional
activity in mismatch repair assays. This residual activity is
reflected in the ability of G674A to form a small population of
sliding clamps and productive ternary complexes with MutL
that support low levels of both 5- and 3-directed excision and
repair. In support of this notion, heterozygousMsh2/GA mice
have similar rates of survival compared with wild type mice
probably reflecting residual MMR activity (1).
In contrast, hMSH2wt-hMSH6T1219D suffers from severe dis-
ruption of normal communication between the nucleotide
binding and mismatch binding domains of MutS despite pos-
sessing composite ATP binding sites that retainATPhydrolysis
activity. Nucleotide-induced conformational changes that nor-
mally occur whenMutS binds to a mismatch fail to take place
in T1219D. Thus the mutant protein fails to assume a sliding
clamp conformation, remains frozen at the mismatch site, and
loses its ability to recruit and activateMutL to carry out 5- or
3-directed excision. This severe MMR deficiency and its
dominant mode of action likely explain why heterozygous
Msh6TD/ mice have a low survival frequency, intermediate
between that ofMsh6/ andMsh6TD/TD mice (2). Identifica-
tion of similar dominant alleles may have important implica-
tions for heterozygous carriers in the human population.
Earlier studies investigating the formation of ternary E. coli
MutS andMutL complexes on mismatched DNA revealed that
ATP binding but not hydrolysis byMutS is required for ternary
complex formation (33, 45, 46). The S. cerevisiae MSH2wt-
MSH6G1067D mutant failed to form ternary complexes despite
apparently normal ATP binding to the MSH6 subunit (24).
FIGURE 6. MutS G674A (GA) and T1219D (TD) fail to assume a sliding clamp conformation on mismatched DNA. A–C, MutS G674A and T1219D failed
to undergo rapid ATP-induced dissociation from a G:T mismatch. DNA binding was monitored by SPR using an unblocked 238-bp G:T heteroduplex (157
response units) and a 238-bp A:T homoduplex (156 response units). 25 nM MutS protein was injected for 5 min followed by running buffer containing no
nucleotide (A), 1 mM ATP (B), or 1 mM ADP (C). D and E, MutS G674A and T1219D fail to assume a sliding clamp conformation in the presence of ATP. An SPR
assay was performed as above, but the 238-bp G:T heteroduplex (167 response units) was blocked at the distal end by the inclusion of LacI in all phases. After
binding of MutS proteins, the dissociation buffer contained either 1 mM ATP and LacI (D) or 1 mM ATP and 1 mM IPTG (E). Binding of LacI alone and subsequent
release by the addition of 1 mM IPTG is indicated in orange.
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These findings suggest that events downstream of ATP binding
to MSH6 in mismatch-bound MutS are critical for recruit-
ment of MutL to a mismatch. Our results support this mech-
anistic scheme for human MutS.
Although our data clearly point to an inability of T1219D
mutant to assume an ATP-dependent conformation at a mis-
match that licenses subsequent steps of MMR, the structural
dynamics underlying this change in MutS are not yet clear.
X-ray crystallographic studies of bacterial MutS-mismatch
complexes with ADP-beryllium fluoride or ATP revealed small
conformational changes in both ATP binding and DNA bind-
ing domains as well as adjacent domains (43, 44). However,
both structures represent intermediates that do not reveal all
the structural transitions required for an activated state of
MutS at amismatch, presumably due to constraints imposed by
crystal contacts. Thr-1219 is unlikely to participate directly in
ATP binding and hydrolysis, as we observe a robust intrinsic
steady-state ATPase rate for the T1219D mutant. Instead, we
speculate that this Thr residue may play an important role in
stabilizing and/or promoting the ATP-activated conformation
ofMutS consistentwith the observation that anHNPCCallele
encoding an MSH6 T1219I mutation confers loss of MMR in
vivo.
MutS can also target mispairs involving damaged or modi-
fied bases such as O6-meG that result from exposure to many
DNA alkylating agents (7, 8). Two models have been proposed
to explain the MMR-dependent DNA damage response: futile
cycle and direct signaling. The “futile cycle” model proposes
that DNA polymerase replicates with low fidelity past the alky-
lated base, incorporating thymine instead of cytosine across
from O6-meG. This situation can lead to reactivation of the
MMR system asO6-meG is in the parent strand and remains in
the DNA. Repeated rounds of futile MMR then activate the
DNA damage response (47–49). Jiricny and co-workers (50)
have reported that exposure to Sn1 DNA alkylators induces the
appearance of single-strand DNA in mammalian cells. Such
single-strand regions complexed to RPA, a single-strand DNA
binding protein, may recruit and activate the ATR kinase and
related checkpoint machinery (51). It is conceivable that cells
harboring the G674A or T1219D mutants, which block exci-
sion at themismatch, accumulate short regions of single-strand
DNA and thus trigger a checkpoint response.
According to the “direct signaling” model, association of
MutS, MutL, and other proteins at the DNA damage site is
sufficient for recruitment of ATR and further activation of
downstreamdamage signaling (52). In vitro studies suggest that
ATR andATRIP can be recruited to sites ofO6-meG:Tmispairs
in a pathway dependent onMutS andMutL (53). Also, it has
been reported that MutS and MutL serve as a scaffold for
recruiting the checkpoint proteins ATR, TopBP1, and Chk1
after treatment with the Sn1 alkylating agent MNNG (54).
Analysis ofMsh2GA/GA andMsh6TD/TD mice reveals normal
apoptotic signaling, as the mutated cells remain sensitive to
several DNA damage adducts such as cisplatin, MNNG, and
6-TG (1, 2). In vitro, hMutS G674A and T1219Dmutant pro-
teins remain bound to the O6meG:T mismatch and can block
5-nick-directed excision in the case of G674A or random exci-
sion in the case of T1219D. As discussed above, the resulting
short regions of gapped DNA may be the direct signal that
induces checkpoint activity. It is also possible that the persist-
ence of hMutSG674A andT1219Dproteins onDNA impedes
key cellular processes such as replication by analogy to the exci-
sion block observed inMMRassays. In any case, themechanism
of damage signaling mediated by hMutS G674A and T1219D
is unlikely to result from futile cycles of MMR.
The data presented here highlight the utility of a careful bio-
chemical analysis of the various steps ofMMRbymutantMMR
proteins, especially hereditary non-polyposis colorectal cancer
alleles.Moreover, although differentmutantsmay appear qual-
itatively similar, detailed functional profiling can aid in identi-
FIGURE 7. MutS mutants are unable to interact with MutL. The ability of MutS proteins to form a ternary complex with MutL was measured by SPR on
a 238-bp G:T heteroduplex DNA substrate (167 response units). 25 nM MutS proteins WT (A), G674A (B), or T1219D (C) and 1 mM ATP were injected alone for
10 min (dotted line) or for 5 min followed by the addition of 25 nM MutL for another 5 min (solid line) as indicated.
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fication of mutants that can be exploited to address unsolved
problems, for example, the conformational changes in MutS
induced by mismatch and nucleotide binding in MMR and the
basis for the apoptotic response to DNA damaging agents in
MMR-proficient mammalian cells.
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